epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Inzirqo

hydrochlorothiazide

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  SUSPENSION: 10 mg per mL

HTN

[12.5-50 mg PO qd]
Start: 12.5-25 mg PO qd; Max: 50 mg/day

edema, adjunct tx

[25-100 mg PO qd]
Alt: may be dosed qod or 3-5x/wk; Info: in heart failure patients, start 25 mg PO qd-bid, max 200 mg/day

calcium nephrolithiasis prevention (off-label)

[25-50 mg/day PO divided qd-bid]
Info: for patients with hypercalcinuria

renal dosing

[see below]
CrCl <10: avoid use; anuria: contraindicated
HD/PD: avoid use

hepatic dosing

[see below]
hepatic impairment/progressive hepatic disease: not defined, caution advised

Peds Dosing .

Dosage forms:  SUSPENSION: 10 mg per mL

HTN

[<6 mo]
Dose: 1-3 mg/kg/day PO divided bid; Max: 37.5 mg/day
[6 mo-2 yo]
Dose: 1-2 mg/kg/day PO divided qd-bid; Max: 37.5 mg/day
[2-12 yo]
Dose: 1-2 mg/kg/day PO divided qd-bid; Max: 100 mg/day

edema, adjunct tx

[<6 mo]
Dose: 1-3 mg/kg/day PO divided bid; Max: 37.5 mg/day
[6 mo-2 yo]
Dose: 1-2 mg/kg/day PO divided qd-bid; Max: 37.5 mg/day
[2-12 yo]
Dose: 1-2 mg/kg/day PO divided qd-bid; Max: 100 mg/day

bronchopulmonary dysplasia (off-label)

[<24 mo]
Dose: 2-4 mg/kg/day PO divided bid

calcium nephrolithiasis prevention (off-label)

[children]
Dose: 0.5-1 mg/kg/day PO divided qd-bid; Max: 50 mg/day; Info: for patients with hypercalcinuria; may incr. dose to 2 mg/kg/day PO divided qd-bid after 3mo if hypercalciuria persists

renal dosing

[see below]
CrCl <10: avoid use; anuria: contraindicated
HD/PD: avoid use

hepatic dosing

[see below]
hepatic impairment/progressive hepatic disease: not defined, caution advised

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@73ff5d7a
  • hypersensitivity to drug or ingredient
  • breastfeeding (>50 mg/day dose)
  • anuria
  • CrCl <10
  • neonatal jaundice
  • avoid: sun exposure
  • avoid: UV light exposure, artificial
  • caution: hypersensitivity to sulfonamides
  • caution: elderly patients
  • caution: White patients (incr. risk of skin CA with >50,000 mg cumulative dose)
  • caution: renal impairment
  • caution: hepatic impairment
  • caution: hepatic disease, progressive
  • caution: electrolyte abnormalities
  • caution: volume depletion
  • caution: diabetes mellitus
  • caution: seizure disorder
  • caution: HTN, gestational
  • caution: SLE
  • caution: gout history
  • caution: pancreatitis history

Drug Interactions .

Overview

hydrochlorothiazide

thiazide diuretic

Interaction Characteristics:
  • affected by altered gastrointestinal motility
  • antihypertensive agent
  • binds to anion exchange resin/polymer
  • decreases renal perfusion/fxn
  • diuretic
  • hypercalcemia
  • hyperglycemic effects
  • hyperuricemic effects
  • hypokalemia
  • hypomagnesemia
  • hyponatremia
  • photosensitivity
  • urine alkalinizer

Contraindicated

  • dofetilide
  • Inzirqo (hydrochlorothiazide)
    +
    dofetilide
    1 interaction

    Contraindicated

    hydrochlorothiazide + dofetilide

    contraindicated: combo may incr. dofetilide levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (mechanism unknown, renal excretion possibly decreased)

  • isocarboxazid
  • Inzirqo (hydrochlorothiazide)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    hydrochlorothiazide + isocarboxazid

    contraindicated: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methenamine
  • Inzirqo (hydrochlorothiazide)
    +
    methenamine
    1 interaction

    Contraindicated

    hydrochlorothiazide + methenamine

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

Avoid/Use Alternative

  • aldesleukin
  • Inzirqo (hydrochlorothiazide)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, renal impairment (additive effects)

  • amikacin
  • Inzirqo (hydrochlorothiazide)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • aminolevulinic acid topical
  • Inzirqo (hydrochlorothiazide)
    +
    aminolevulinic acid topical
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + aminolevulinic acid topical

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • aripiprazole lauroxil
  • Inzirqo (hydrochlorothiazide)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + aripiprazole lauroxil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorothiazide
  • Inzirqo (hydrochlorothiazide)
    +
    chlorothiazide
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + chlorothiazide

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, seizures, hypokalemia, cardiac arrhythmias, hypomagnesemia, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • chlorthalidone
  • Inzirqo (hydrochlorothiazide)
    +
    chlorthalidone
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + chlorthalidone

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, hypokalemia, hypomagnesemia, cardiac arrhythmias, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • clofarabine
  • Inzirqo (hydrochlorothiazide)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + clofarabine

    avoid hydrochlorothiazide during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, severe hypotension, other adverse effects (additive effects)

  • hydrochlorothiazide
  • Inzirqo (hydrochlorothiazide)
    +
    hydrochlorothiazide
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + hydrochlorothiazide

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, hypokalemia, hypercalcemia, hypomagnesemia, cardiac arrhythmias, other adverse effects (additive effects, duplicate therapy)

  • indapamide
  • Inzirqo (hydrochlorothiazide)
    +
    indapamide
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + indapamide

    avoid combo: combo may incr. risk of renal impairment, severe hyponatremia, hypokalemia, hypercalcemia, hypomagnesemia, cardiac arrhythmias, other adverse effects (additive effects, duplicate therapy)

  • iodixanol
  • Inzirqo (hydrochlorothiazide)
    +
    iodixanol
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + iodixanol

    avoid hydrochlorothiazide prior to iodixanol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • iomeprol
  • Inzirqo (hydrochlorothiazide)
    +
    iomeprol
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + iomeprol

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • iopromide
  • Inzirqo (hydrochlorothiazide)
    +
    iopromide
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + iopromide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • ioversol
  • Inzirqo (hydrochlorothiazide)
    +
    ioversol
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + ioversol

    avoid hydrochlorothiazide prior to ioversol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • lofexidine
  • Inzirqo (hydrochlorothiazide)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mannitol
  • Inzirqo (hydrochlorothiazide)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + mannitol

    use alternative or monitor renal fxn, potassium, sodium, ECG: combo may incr. mannitol levels, risk of renal impairment, hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia (including life-threatening), seizures, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • metolazone
  • Inzirqo (hydrochlorothiazide)
    +
    metolazone
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + metolazone

    avoid combo: combo may incr. risk of renal impairment, hyponatremia (including life-threatening), hypokalemia, hypercalcemia, hypomagnesemia, cardiac arrhythmias, other adverse effects (additive effects, duplicate therapy)

  • porfimer
  • Inzirqo (hydrochlorothiazide)
    +
    porfimer
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + porfimer

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • sulfamethoxazole
  • Inzirqo (hydrochlorothiazide)
    +
    sulfamethoxazole
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + sulfamethoxazole

    avoid combo especially in elderly pts: combo may incr. risk of thrombocytopenia (mechanism unknown)

  • tretinoin topical
  • Inzirqo (hydrochlorothiazide)
    +
    tretinoin topical
    1 interaction

    Avoid/Use Alternative

    hydrochlorothiazide + tretinoin topical

    consider alternative, especially if tretinoin topical cosmetic use: combo may incr. risk of phototoxicity or augment phototoxic reaction (possible additive effects)

Monitor/Modify Tx

  • abaloparatide
  • Inzirqo (hydrochlorothiazide)
    +
    abaloparatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + abaloparatide

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • abiraterone acetate
  • Inzirqo (hydrochlorothiazide)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + abiraterone acetate

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • acarbose
  • Inzirqo (hydrochlorothiazide)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acetazolamide
  • Inzirqo (hydrochlorothiazide)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + acetazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • acyclovir
  • Inzirqo (hydrochlorothiazide)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + acyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Inzirqo (hydrochlorothiazide)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + adefovir dipivoxil

    monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased, additive effects)

  • albuterol
  • Inzirqo (hydrochlorothiazide)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + albuterol

    monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • albuterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + albuterol inhaled

    monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • alfentanil
  • Inzirqo (hydrochlorothiazide)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • alfuzosin
  • Inzirqo (hydrochlorothiazide)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • allopurinol
  • Inzirqo (hydrochlorothiazide)
    +
    allopurinol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + allopurinol

    monitor renal fxn, uric acid levels: combo may incr. risk of nephrotoxicity; may decr. allopurinol efficacy (additive effects; antagonistic effects)

  • almotriptan
  • Inzirqo (hydrochlorothiazide)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + almotriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • aloe
  • Inzirqo (hydrochlorothiazide)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + aloe

    monitor potassium w/ aloe laxative doses: combo may incr. risk of hypokalemia (additive effects)

  • alogliptin
  • Inzirqo (hydrochlorothiazide)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Inzirqo (hydrochlorothiazide)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Inzirqo (hydrochlorothiazide)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amantadine

    monitor BP: combo may incr. levels of both drugs, risk of hypotension (including orthostasis, syncope), other adverse effects (renal excretion possibly decreased at higher urine pH, absorption increased, additive effects)

  • amifostine
  • Inzirqo (hydrochlorothiazide)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amifostine

    D/C hydrochlorothiazide 24h before amifostine admin.; monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amikacin inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    amikacin inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amikacin inhaled

    monitor renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amiloride
  • Inzirqo (hydrochlorothiazide)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amiloride

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • amitriptyline
  • Inzirqo (hydrochlorothiazide)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amitriptyline

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • amoxapine
  • Inzirqo (hydrochlorothiazide)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amoxapine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • amphetamine
  • Inzirqo (hydrochlorothiazide)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphotericin
  • Inzirqo (hydrochlorothiazide)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + amphotericin

    monitor renal fxn, magnesium, potassium, ECG: combo may incr. risk of nephrotoxicity, hypomagnesemia, hypokalemia, cardiac arrhythmias (additive effects)

  • anthrax immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + anthrax immune globulin

    monitor renal fxn; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • apomorphine
  • Inzirqo (hydrochlorothiazide)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension (additive effects)

  • arformoterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + arformoterol inhaled

    monitor BP, potassium: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • aripiprazole bimonthly injection
  • Inzirqo (hydrochlorothiazide)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole monthly injection
  • Inzirqo (hydrochlorothiazide)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Inzirqo (hydrochlorothiazide)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • armodafinil
  • Inzirqo (hydrochlorothiazide)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + armodafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arsenic trioxide
  • Inzirqo (hydrochlorothiazide)
    +
    arsenic trioxide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + arsenic trioxide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • articaine
  • Inzirqo (hydrochlorothiazide)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + articaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • asciminib
  • Inzirqo (hydrochlorothiazide)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + asciminib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • asenapine
  • Inzirqo (hydrochlorothiazide)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • asparaginase
  • Inzirqo (hydrochlorothiazide)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + asparaginase

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • aspirin
  • Inzirqo (hydrochlorothiazide)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + aspirin

    monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • atogepant
  • Inzirqo (hydrochlorothiazide)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + atogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Inzirqo (hydrochlorothiazide)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + atomoxetine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atropine ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + atropine ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • auranofin
  • Inzirqo (hydrochlorothiazide)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + auranofin

    monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avanafil
  • Inzirqo (hydrochlorothiazide)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • axitinib
  • Inzirqo (hydrochlorothiazide)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + axitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • azilsartan medoxomil
  • Inzirqo (hydrochlorothiazide)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + azilsartan medoxomil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • balsalazide
  • Inzirqo (hydrochlorothiazide)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + balsalazide

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • benazepril
  • Inzirqo (hydrochlorothiazide)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + benazepril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • benzphetamine
  • Inzirqo (hydrochlorothiazide)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + benzphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • berberine
  • Inzirqo (hydrochlorothiazide)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • betamethasone
  • Inzirqo (hydrochlorothiazide)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + betamethasone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • betaxolol ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bethanechol
  • Inzirqo (hydrochlorothiazide)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bevacizumab
  • Inzirqo (hydrochlorothiazide)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bevacizumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bexagliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bismuth subsalicylate
  • Inzirqo (hydrochlorothiazide)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bortezomib
  • Inzirqo (hydrochlorothiazide)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • botulism immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + botulism immune globulin

    monitor renal fxn; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • brexpiprazole
  • Inzirqo (hydrochlorothiazide)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brigatinib
  • Inzirqo (hydrochlorothiazide)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + brigatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brimonidine ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Inzirqo (hydrochlorothiazide)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Inzirqo (hydrochlorothiazide)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • budesonide
  • Inzirqo (hydrochlorothiazide)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + budesonide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • bumetanide
  • Inzirqo (hydrochlorothiazide)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bumetanide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias, other adverse effects (additive effects, duplicate therapy)

  • bupivacaine
  • Inzirqo (hydrochlorothiazide)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bupivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bupivacaine liposomal
  • Inzirqo (hydrochlorothiazide)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • buprenorphine
  • Inzirqo (hydrochlorothiazide)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • bupropion
  • Inzirqo (hydrochlorothiazide)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + bupropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • burosumab
  • Inzirqo (hydrochlorothiazide)
    +
    burosumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + burosumab

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • butalbital
  • Inzirqo (hydrochlorothiazide)
    +
    butalbital
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + butalbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • butorphanol
  • Inzirqo (hydrochlorothiazide)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + butorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • cabergoline
  • Inzirqo (hydrochlorothiazide)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabozantinib
  • Inzirqo (hydrochlorothiazide)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cabozantinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine
  • Inzirqo (hydrochlorothiazide)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + caffeine

    monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine citrate
  • Inzirqo (hydrochlorothiazide)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + caffeine citrate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • calcipotriene topical
  • Inzirqo (hydrochlorothiazide)
    +
    calcipotriene topical
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcipotriene topical

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcitriol
  • Inzirqo (hydrochlorothiazide)
    +
    calcitriol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcitriol

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcitriol topical
  • Inzirqo (hydrochlorothiazide)
    +
    calcitriol topical
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcitriol topical

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium acetate
  • Inzirqo (hydrochlorothiazide)
    +
    calcium acetate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcium acetate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium carbonate
  • Inzirqo (hydrochlorothiazide)
    +
    calcium carbonate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcium carbonate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium chloride
  • Inzirqo (hydrochlorothiazide)
    +
    calcium chloride
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcium chloride

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium citrate
  • Inzirqo (hydrochlorothiazide)
    +
    calcium citrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcium citrate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium gluconate
  • Inzirqo (hydrochlorothiazide)
    +
    calcium gluconate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + calcium gluconate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • canagliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Inzirqo (hydrochlorothiazide)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + candesartan cilexetil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • cannabis
  • Inzirqo (hydrochlorothiazide)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cannabis

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • capecitabine
  • Inzirqo (hydrochlorothiazide)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + capecitabine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • captopril
  • Inzirqo (hydrochlorothiazide)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + captopril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • carbamazepine
  • Inzirqo (hydrochlorothiazide)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + carbamazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • carboplatin
  • Inzirqo (hydrochlorothiazide)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + carboplatin

    monitor CBC, renal fxn, magnesium: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, hypomagnesemia, cardiac arrhythmias, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Inzirqo (hydrochlorothiazide)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + carfilzomib

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cariprazine
  • Inzirqo (hydrochlorothiazide)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • celecoxib
  • Inzirqo (hydrochlorothiazide)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + celecoxib

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • cetuximab
  • Inzirqo (hydrochlorothiazide)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cetuximab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • chloroprocaine
  • Inzirqo (hydrochlorothiazide)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + chloroprocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • chlorpromazine
  • Inzirqo (hydrochlorothiazide)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + chlorpromazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis, syncope), other adverse effects (absorption increased, additive effects)

  • cholecalciferol (vitamin D3)
  • Inzirqo (hydrochlorothiazide)
    +
    cholecalciferol (vitamin D3)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cholecalciferol (vitamin D3)

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • cholestyramine
  • Inzirqo (hydrochlorothiazide)
    +
    cholestyramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cholestyramine

    give hydrochlorothiazide at least 4h before or 4-6h after each cholestyramine dose: combo may decr. hydrochlorothiazide levels, efficacy (absorption decreased/delayed)

  • cidofovir
  • Inzirqo (hydrochlorothiazide)
    +
    cidofovir
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cidofovir

    monitor CBC, renal fxn: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • cilostazol
  • Inzirqo (hydrochlorothiazide)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cisplatin
  • Inzirqo (hydrochlorothiazide)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cisplatin

    monitor CBC, renal fxn, electrolytes, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias, tetany, auditory, vestibular, other adverse effects (additive effects)

  • citalopram
  • Inzirqo (hydrochlorothiazide)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + citalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • clindamycin
  • Inzirqo (hydrochlorothiazide)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + clindamycin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clomipramine
  • Inzirqo (hydrochlorothiazide)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + clomipramine

    monitor BP, sodium: combo may incr. hydrochlorothiazide levels, risk of hyponatremia, hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • clonidine
  • Inzirqo (hydrochlorothiazide)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Inzirqo (hydrochlorothiazide)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + clozapine

    monitor BP, HR: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis, syncope), other adverse effects (absorption increased, additive effects)

  • cocaine
  • Inzirqo (hydrochlorothiazide)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cocaine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • codeine
  • Inzirqo (hydrochlorothiazide)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + codeine

    monitor BP: combo may decr. hydrochlorothiazide efficacy; may incr. risk of severe hypotension, including orthostasis, syncope (antagonistic effects, opioids may induce antidiuretic hormone release; additive effects)

  • coenzyme Q-10
  • Inzirqo (hydrochlorothiazide)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • colesevelam
  • Inzirqo (hydrochlorothiazide)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • colestipol
  • Inzirqo (hydrochlorothiazide)
    +
    colestipol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + colestipol

    give hydrochlorothiazide at least 4h before or 4-6h after each colestipol dose: combo may decr. hydrochlorothiazide levels, efficacy (absorption decreased/delayed)

  • colistimethate
  • Inzirqo (hydrochlorothiazide)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + colistimethate

    monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • copanlisib
  • Inzirqo (hydrochlorothiazide)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + copanlisib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects, copanlisib may cause infusion-related HTN)

  • copper histidinate
  • Inzirqo (hydrochlorothiazide)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + copper histidinate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • corticotropin
  • Inzirqo (hydrochlorothiazide)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + corticotropin

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cortisone
  • Inzirqo (hydrochlorothiazide)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • creatine
  • Inzirqo (hydrochlorothiazide)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + creatine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • crizotinib
  • Inzirqo (hydrochlorothiazide)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + crizotinib

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • cyclophosphamide
  • Inzirqo (hydrochlorothiazide)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cyclophosphamide

    monitor CBC, renal, cardiac fxn, sodium: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, hyponatremia (including life-threatening), other adverse effects (additive effects)

  • cyclosporine
  • Inzirqo (hydrochlorothiazide)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cyclosporine

    monitor renal fxn, magnesium, BP: combo may incr. risk of nephrotoxicity, hypomagnesemia, cardiac arrhythmias, seizures; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cytomegalovirus immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + cytomegalovirus immune globulin

    monitor renal fxn; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • danazol
  • Inzirqo (hydrochlorothiazide)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + danazol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dapagliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dapagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • darbepoetin alfa
  • Inzirqo (hydrochlorothiazide)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + darbepoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • decitabine
  • Inzirqo (hydrochlorothiazide)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + decitabine

    monitor potassium w/ IV decitabine use: combo may incr. risk of hypokalemia (additive effects)

  • deferasirox
  • Inzirqo (hydrochlorothiazide)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + deferasirox

    monitor CBC, renal fxn, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Inzirqo (hydrochlorothiazide)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + deferoxamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • deflazacort
  • Inzirqo (hydrochlorothiazide)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + deflazacort

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • denileukin diftitox
  • Inzirqo (hydrochlorothiazide)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Inzirqo (hydrochlorothiazide)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + desflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • desipramine
  • Inzirqo (hydrochlorothiazide)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + desipramine

    monitor BP, sodium: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), hyponatremia, other adverse effects (absorption increased, additive effects)

  • desmopressin
  • Inzirqo (hydrochlorothiazide)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + desmopressin

    monitor sodium, BP: combo may incr. risk of hyponatremia, including life-threatening; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • desvenlafaxine
  • Inzirqo (hydrochlorothiazide)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + desvenlafaxine

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • dexamethasone
  • Inzirqo (hydrochlorothiazide)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dexamethasone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • dexlansoprazole
  • Inzirqo (hydrochlorothiazide)
    +
    dexlansoprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dexlansoprazole

    monitor magnesium, especially w/ dexlansoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • dexmedetomidine
  • Inzirqo (hydrochlorothiazide)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Inzirqo (hydrochlorothiazide)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • dexmethylphenidate
  • Inzirqo (hydrochlorothiazide)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dexmethylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dextroamphetamine
  • Inzirqo (hydrochlorothiazide)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dextroamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diazoxide
  • Inzirqo (hydrochlorothiazide)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + diazoxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • dichlorphenamide
  • Inzirqo (hydrochlorothiazide)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dichlorphenamide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • diclofenac
  • Inzirqo (hydrochlorothiazide)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + diclofenac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • diclofenac topical
  • Inzirqo (hydrochlorothiazide)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + diclofenac topical

    monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • diethylpropion
  • Inzirqo (hydrochlorothiazide)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + diethylpropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diflunisal
  • Inzirqo (hydrochlorothiazide)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + diflunisal

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • digoxin
  • Inzirqo (hydrochlorothiazide)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + digoxin

    monitor electrolytes: combo may incr. risk of digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities may incr. digoxin sensitivity)

  • dihydrocodeine
  • Inzirqo (hydrochlorothiazide)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • dihydroergotamine
  • Inzirqo (hydrochlorothiazide)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dihydroergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dinutuximab
  • Inzirqo (hydrochlorothiazide)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dinutuximab

    monitor BP, potassium, sodium: combo may incr. risk of severe hypotension, severe hyponatremia, hypokalemia (additive effects)

  • dipyridamole
  • Inzirqo (hydrochlorothiazide)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • doxapram
  • Inzirqo (hydrochlorothiazide)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + doxapram

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxazosin
  • Inzirqo (hydrochlorothiazide)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Inzirqo (hydrochlorothiazide)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + doxepin

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • doxercalciferol
  • Inzirqo (hydrochlorothiazide)
    +
    doxercalciferol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + doxercalciferol

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • dronabinol
  • Inzirqo (hydrochlorothiazide)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dronabinol

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • droxidopa
  • Inzirqo (hydrochlorothiazide)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + droxidopa

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • dulaglutide
  • Inzirqo (hydrochlorothiazide)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Inzirqo (hydrochlorothiazide)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + duloxetine

    monitor BP, sodium: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • eletriptan
  • Inzirqo (hydrochlorothiazide)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + eletriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • emapalumab
  • Inzirqo (hydrochlorothiazide)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + emapalumab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • empagliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + empagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • enalapril
  • Inzirqo (hydrochlorothiazide)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + enalapril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • enalaprilat
  • Inzirqo (hydrochlorothiazide)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + enalaprilat

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • entacapone
  • Inzirqo (hydrochlorothiazide)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Inzirqo (hydrochlorothiazide)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ephedra
  • Inzirqo (hydrochlorothiazide)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ephedra

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Inzirqo (hydrochlorothiazide)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ephedrine injection

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine oral
  • Inzirqo (hydrochlorothiazide)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ephedrine oral

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine
  • Inzirqo (hydrochlorothiazide)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + epinephrine

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • epinephrine inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    epinephrine inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + epinephrine inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Inzirqo (hydrochlorothiazide)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + epoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoprostenol
  • Inzirqo (hydrochlorothiazide)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • eptinezumab
  • Inzirqo (hydrochlorothiazide)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + eptinezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • erenumab
  • Inzirqo (hydrochlorothiazide)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + erenumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ergocalciferol (vitamin D2)
  • Inzirqo (hydrochlorothiazide)
    +
    ergocalciferol (vitamin D2)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ergocalciferol (vitamin D2)

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • ergotamine
  • Inzirqo (hydrochlorothiazide)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ertugliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ertugliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • escitalopram
  • Inzirqo (hydrochlorothiazide)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + escitalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • esketamine
  • Inzirqo (hydrochlorothiazide)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + esketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • eslicarbazepine acetate
  • Inzirqo (hydrochlorothiazide)
    +
    eslicarbazepine acetate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + eslicarbazepine acetate

    monitor sodium: combo may incr. risk of hyponatremia (including life-threatening), seizures (additive effects)

  • esomeprazole
  • Inzirqo (hydrochlorothiazide)
    +
    esomeprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + esomeprazole

    monitor magnesium, especially w/ esomeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • estetrol (contraceptive)
  • Inzirqo (hydrochlorothiazide)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + estetrol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Inzirqo (hydrochlorothiazide)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethacrynic acid
  • Inzirqo (hydrochlorothiazide)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ethacrynic acid

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • ethanol (alcoholic beverage)
  • Inzirqo (hydrochlorothiazide)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ethanol (alcoholic beverage)

    monitor BP: combo may alter BP control, initially incr. risk of severe hypotension, followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • ethanol injection
  • Inzirqo (hydrochlorothiazide)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethinyl estradiol (contraceptive)
  • Inzirqo (hydrochlorothiazide)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ethinyl estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etodolac
  • Inzirqo (hydrochlorothiazide)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + etodolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • etrasimod
  • Inzirqo (hydrochlorothiazide)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + etrasimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etripamil nasal
  • Inzirqo (hydrochlorothiazide)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • exenatide
  • Inzirqo (hydrochlorothiazide)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fenfluramine
  • Inzirqo (hydrochlorothiazide)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fenfluramine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Inzirqo (hydrochlorothiazide)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fenoprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • fentanyl
  • Inzirqo (hydrochlorothiazide)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • ferumoxytol
  • Inzirqo (hydrochlorothiazide)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • fingolimod
  • Inzirqo (hydrochlorothiazide)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fingolimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • flaxseed
  • Inzirqo (hydrochlorothiazide)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flibanserin
  • Inzirqo (hydrochlorothiazide)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • flucytosine
  • Inzirqo (hydrochlorothiazide)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + flucytosine

    monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludrocortisone
  • Inzirqo (hydrochlorothiazide)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fludrocortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • fluoxetine
  • Inzirqo (hydrochlorothiazide)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fluoxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • fluphenazine
  • Inzirqo (hydrochlorothiazide)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fluphenazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • flurbiprofen
  • Inzirqo (hydrochlorothiazide)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + flurbiprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • fluvoxamine
  • Inzirqo (hydrochlorothiazide)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fluvoxamine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • formoterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + formoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • foscarnet
  • Inzirqo (hydrochlorothiazide)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + foscarnet

    monitor CBC, renal fxn, magnesium, potassium, ECG: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias, tetany, seizures, other adverse effects (additive effects)

  • fosfomycin injection
  • Inzirqo (hydrochlorothiazide)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fosfomycin injection

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • foslevodopa
  • Inzirqo (hydrochlorothiazide)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fostamatinib
  • Inzirqo (hydrochlorothiazide)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fostamatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fremanezumab
  • Inzirqo (hydrochlorothiazide)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fremanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • frovatriptan
  • Inzirqo (hydrochlorothiazide)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + frovatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fruquintinib
  • Inzirqo (hydrochlorothiazide)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + fruquintinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • furosemide
  • Inzirqo (hydrochlorothiazide)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + furosemide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • galcanezumab
  • Inzirqo (hydrochlorothiazide)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + galcanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ganciclovir
  • Inzirqo (hydrochlorothiazide)
    +
    ganciclovir
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • garlic
  • Inzirqo (hydrochlorothiazide)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gentamicin
  • Inzirqo (hydrochlorothiazide)
    +
    gentamicin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + gentamicin

    monitor gentamicin levels, renal fxn, magnesium, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, hypomagnesemia, cardiac arrhythmias, tetany, auditory, vestibular, other adverse effects (additive effects)

  • gilteritinib
  • Inzirqo (hydrochlorothiazide)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • glimepiride
  • Inzirqo (hydrochlorothiazide)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Inzirqo (hydrochlorothiazide)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Inzirqo (hydrochlorothiazide)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Inzirqo (hydrochlorothiazide)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Inzirqo (hydrochlorothiazide)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hoodia
  • Inzirqo (hydrochlorothiazide)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hoodia

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydralazine
  • Inzirqo (hydrochlorothiazide)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hydralazine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • hydrocodone
  • Inzirqo (hydrochlorothiazide)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydrocortisone
  • Inzirqo (hydrochlorothiazide)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hydrocortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • hydromorphone
  • Inzirqo (hydrochlorothiazide)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydroxocobalamin IV
  • Inzirqo (hydrochlorothiazide)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + hydroxocobalamin IV

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibrutinib
  • Inzirqo (hydrochlorothiazide)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ibrutinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibuprofen
  • Inzirqo (hydrochlorothiazide)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ibuprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • ibuprofen lysine
  • Inzirqo (hydrochlorothiazide)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ibuprofen lysine

    monitor renal fxn: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • ifosfamide
  • Inzirqo (hydrochlorothiazide)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ifosfamide

    monitor CBC, sodium, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, hyponatremia, other adverse effects (additive effects)

  • iloperidone
  • Inzirqo (hydrochlorothiazide)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Inzirqo (hydrochlorothiazide)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iloprost

    monitor BP; consider holding hydrochlorothiazide during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Inzirqo (hydrochlorothiazide)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + imipramine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + immune globulin

    monitor renal fxn; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • indomethacin
  • Inzirqo (hydrochlorothiazide)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + indomethacin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • insulin
  • Inzirqo (hydrochlorothiazide)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + insulin

    monitor glucose, potassium: combo may incr. risk of hypokalemia; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • iohexol
  • Inzirqo (hydrochlorothiazide)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iohexol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iopamidol
  • Inzirqo (hydrochlorothiazide)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iopamidol

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iothalamate meglumine
  • Inzirqo (hydrochlorothiazide)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity (additive effects)

  • irbesartan
  • Inzirqo (hydrochlorothiazide)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + irbesartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • iron sucrose
  • Inzirqo (hydrochlorothiazide)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Inzirqo (hydrochlorothiazide)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + isoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoproterenol
  • Inzirqo (hydrochlorothiazide)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + isoproterenol

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • isosorbide dinitrate
  • Inzirqo (hydrochlorothiazide)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + isosorbide dinitrate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isosorbide mononitrate
  • Inzirqo (hydrochlorothiazide)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + isosorbide mononitrate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ketamine
  • Inzirqo (hydrochlorothiazide)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketoprofen
  • Inzirqo (hydrochlorothiazide)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ketoprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • ketorolac
  • Inzirqo (hydrochlorothiazide)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ketorolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • landiolol
  • Inzirqo (hydrochlorothiazide)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + landiolol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • lanreotide
  • Inzirqo (hydrochlorothiazide)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lanreotide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lansoprazole
  • Inzirqo (hydrochlorothiazide)
    +
    lansoprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lansoprazole

    monitor magnesium, especially w/ lansoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • leflunomide
  • Inzirqo (hydrochlorothiazide)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + leflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lenalidomide
  • Inzirqo (hydrochlorothiazide)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lenalidomide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • lenvatinib
  • Inzirqo (hydrochlorothiazide)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lenvatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • leucovorin
  • Inzirqo (hydrochlorothiazide)
    +
    leucovorin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + leucovorin

    monitor calcium: combo may increase risk of hypercalcemia (additive effects, (levo)leucovorin injection contains calcium)

  • levalbuterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levalbuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levobunolol ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • levodopa
  • Inzirqo (hydrochlorothiazide)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levomilnacipran
  • Inzirqo (hydrochlorothiazide)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levomilnacipran

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levorphanol
  • Inzirqo (hydrochlorothiazide)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • levothyroxine
  • Inzirqo (hydrochlorothiazide)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + levothyroxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • licorice
  • Inzirqo (hydrochlorothiazide)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + licorice

    monitor BP, potassium w/ large amounts of licorice: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • lidocaine
  • Inzirqo (hydrochlorothiazide)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lidocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • linagliptin
  • Inzirqo (hydrochlorothiazide)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • linezolid
  • Inzirqo (hydrochlorothiazide)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + linezolid

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • liothyronine
  • Inzirqo (hydrochlorothiazide)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + liothyronine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • liraglutide
  • Inzirqo (hydrochlorothiazide)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisdexamfetamine
  • Inzirqo (hydrochlorothiazide)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lisdexamfetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lisinopril
  • Inzirqo (hydrochlorothiazide)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lisinopril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • lithium
  • Inzirqo (hydrochlorothiazide)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lithium

    monitor lithium levels, renal fxn; consider decr. lithium start dose: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lixisenatide
  • Inzirqo (hydrochlorothiazide)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lomustine
  • Inzirqo (hydrochlorothiazide)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lomustine

    monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lorlatinib
  • Inzirqo (hydrochlorothiazide)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lorlatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • losartan
  • Inzirqo (hydrochlorothiazide)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + losartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • loxapine
  • Inzirqo (hydrochlorothiazide)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + loxapine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis, syncope), other adverse effects (absorption increased, additive effects)

  • lubiprostone
  • Inzirqo (hydrochlorothiazide)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumacaftor/ivacaftor
  • Inzirqo (hydrochlorothiazide)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lumacaftor/ ivacaftor

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumateperone
  • Inzirqo (hydrochlorothiazide)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Inzirqo (hydrochlorothiazide)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • luspatercept
  • Inzirqo (hydrochlorothiazide)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + luspatercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lutetium Lu 177 dotatate
  • Inzirqo (hydrochlorothiazide)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lutetium Lu 177 dotatate

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Inzirqo (hydrochlorothiazide)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + lutetium Lu 177 vipivotide tetraxetan

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Inzirqo (hydrochlorothiazide)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + magnesium citrate

    monitor renal fxn, sodium, potassium, consider monitoring ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, renal impairment, hyponatremia, seizures (additive effects)

  • magnesium salicylate
  • Inzirqo (hydrochlorothiazide)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + magnesium salicylate

    monitor renal fxn, BP w/ high-dose magnesium salicylate: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • magnesium sulfate
  • Inzirqo (hydrochlorothiazide)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Inzirqo (hydrochlorothiazide)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meclofenamate
  • Inzirqo (hydrochlorothiazide)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + meclofenamate

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • mefenamic acid
  • Inzirqo (hydrochlorothiazide)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mefenamic acid

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • meloxicam
  • Inzirqo (hydrochlorothiazide)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + meloxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • meperidine
  • Inzirqo (hydrochlorothiazide)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • mepivacaine
  • Inzirqo (hydrochlorothiazide)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mepivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • mesalamine
  • Inzirqo (hydrochlorothiazide)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mesalamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Inzirqo (hydrochlorothiazide)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mesalamine rectal

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • metformin
  • Inzirqo (hydrochlorothiazide)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Inzirqo (hydrochlorothiazide)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • methamphetamine
  • Inzirqo (hydrochlorothiazide)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methazolamide
  • Inzirqo (hydrochlorothiazide)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • methohexital
  • Inzirqo (hydrochlorothiazide)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methotrexate
  • Inzirqo (hydrochlorothiazide)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Inzirqo (hydrochlorothiazide)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylene blue injection
  • Inzirqo (hydrochlorothiazide)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylergonovine
  • Inzirqo (hydrochlorothiazide)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methylergonovine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Inzirqo (hydrochlorothiazide)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Inzirqo (hydrochlorothiazide)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methylprednisolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • methyltestosterone
  • Inzirqo (hydrochlorothiazide)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + methyltestosterone

    monitor BP, calcium, especially if breast CA use: combo may incr. risk of hypercalcemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • metoclopramide
  • Inzirqo (hydrochlorothiazide)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + metoclopramide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • midazolam
  • Inzirqo (hydrochlorothiazide)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midodrine
  • Inzirqo (hydrochlorothiazide)
    +
    midodrine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + midodrine

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • mifepristone
  • Inzirqo (hydrochlorothiazide)
    +
    mifepristone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mifepristone

    monitor potassium if daily mifepristone use: combo may incr. risk of hypokalemia (additive effects)

  • miglitol
  • Inzirqo (hydrochlorothiazide)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • Inzirqo (hydrochlorothiazide)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + milnacipran

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • milrinone
  • Inzirqo (hydrochlorothiazide)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Inzirqo (hydrochlorothiazide)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirabegron
  • Inzirqo (hydrochlorothiazide)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mirabegron

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirtazapine
  • Inzirqo (hydrochlorothiazide)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mirtazapine

    monitor sodium, BP: combo may incr. hydrochlorothiazide levels, risk of hyponatremia, hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • mitomycin
  • Inzirqo (hydrochlorothiazide)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + mitomycin

    monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • modafinil
  • Inzirqo (hydrochlorothiazide)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + modafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • moexipril
  • Inzirqo (hydrochlorothiazide)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + moexipril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • molindone
  • Inzirqo (hydrochlorothiazide)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + molindone

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • morphine
  • Inzirqo (hydrochlorothiazide)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • motixafortide
  • Inzirqo (hydrochlorothiazide)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + motixafortide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • nabumetone
  • Inzirqo (hydrochlorothiazide)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nabumetone

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • nalbuphine
  • Inzirqo (hydrochlorothiazide)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • naphazoline ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + naphazoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Inzirqo (hydrochlorothiazide)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + naproxen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • naratriptan
  • Inzirqo (hydrochlorothiazide)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + naratriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nateglinide
  • Inzirqo (hydrochlorothiazide)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nateglinide

    monitor glucose; consider incr. nateglinide dose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Inzirqo (hydrochlorothiazide)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • naxitamab
  • Inzirqo (hydrochlorothiazide)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + naxitamab

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • necitumumab
  • Inzirqo (hydrochlorothiazide)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + necitumumab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • neomycin
  • Inzirqo (hydrochlorothiazide)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • niacin (vitamin B3)
  • Inzirqo (hydrochlorothiazide)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicotine
  • Inzirqo (hydrochlorothiazide)
    +
    nicotine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nicotine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Inzirqo (hydrochlorothiazide)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nilotinib

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects; antagonistic effects)

  • niraparib
  • Inzirqo (hydrochlorothiazide)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + niraparib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nitric oxide
  • Inzirqo (hydrochlorothiazide)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Inzirqo (hydrochlorothiazide)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Inzirqo (hydrochlorothiazide)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Inzirqo (hydrochlorothiazide)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Inzirqo (hydrochlorothiazide)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nortriptyline

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • nusinersen
  • Inzirqo (hydrochlorothiazide)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + nusinersen

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • obinutuzumab
  • Inzirqo (hydrochlorothiazide)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + obinutuzumab

    monitor BP: combo may incr. risk of hypotension; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olanzapine
  • Inzirqo (hydrochlorothiazide)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + olanzapine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis, syncope), other adverse effects (absorption increased, additive effects)

  • oliceridine
  • Inzirqo (hydrochlorothiazide)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • olmesartan medoxomil
  • Inzirqo (hydrochlorothiazide)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + olmesartan medoxomil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • olodaterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + olodaterol inhaled

    monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia, ECG changes (antagonistic effects; additive effects)

  • olsalazine
  • Inzirqo (hydrochlorothiazide)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + olsalazine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • omeprazole
  • Inzirqo (hydrochlorothiazide)
    +
    omeprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + omeprazole

    monitor magnesium, especially w/ omeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • opicapone
  • Inzirqo (hydrochlorothiazide)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Inzirqo (hydrochlorothiazide)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • osilodrostat
  • Inzirqo (hydrochlorothiazide)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + osilodrostat

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • oxaliplatin
  • Inzirqo (hydrochlorothiazide)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxaliplatin

    monitor ECG, CBC, renal fxn, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • oxaprozin
  • Inzirqo (hydrochlorothiazide)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxaprozin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • oxazepam
  • Inzirqo (hydrochlorothiazide)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxcarbazepine
  • Inzirqo (hydrochlorothiazide)
    +
    oxcarbazepine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxcarbazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • oxycodone
  • Inzirqo (hydrochlorothiazide)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxymetazoline nasal
  • Inzirqo (hydrochlorothiazide)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxymetazoline nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxymetazoline ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline topical
  • Inzirqo (hydrochlorothiazide)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxymetazoline topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymorphone
  • Inzirqo (hydrochlorothiazide)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxytocin
  • Inzirqo (hydrochlorothiazide)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + oxytocin

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects)

  • ozanimod
  • Inzirqo (hydrochlorothiazide)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ozanimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • paliperidone
  • Inzirqo (hydrochlorothiazide)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Inzirqo (hydrochlorothiazide)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + palopegteriparatide

    monitor BP, calcium: combo may incr. risk of hypercalcemia, hypotension, including orthostasis, syncope (additive effects)

  • pamidronate
  • Inzirqo (hydrochlorothiazide)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pamidronate

    monitor renal fxn, potassium, magnesium: combo may incr. pamidronate levels, risk of nephrotoxicity, hypokalemia, hypomagnesemia, cardiac arrhythmias, other adverse effects (additive effects)

  • panitumumab
  • Inzirqo (hydrochlorothiazide)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + panitumumab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • pantoprazole
  • Inzirqo (hydrochlorothiazide)
    +
    pantoprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pantoprazole

    monitor magnesium, especially w/ pantoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • paricalcitol
  • Inzirqo (hydrochlorothiazide)
    +
    paricalcitol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + paricalcitol

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • paromomycin
  • Inzirqo (hydrochlorothiazide)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • paroxetine
  • Inzirqo (hydrochlorothiazide)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + paroxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • patiromer
  • Inzirqo (hydrochlorothiazide)
    +
    patiromer
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + patiromer

    monitor magnesium: combo may incr. risk of hypomagnesemia, cardiac arrhythmias (additive effects)

  • pazopanib
  • Inzirqo (hydrochlorothiazide)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pazopanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pegloticase
  • Inzirqo (hydrochlorothiazide)
    +
    pegloticase
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pegloticase

    monitor uric acid levels: combo may decr. pegloticase efficacy (antagonistic effects)

  • pemetrexed
  • Inzirqo (hydrochlorothiazide)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pemetrexed

    monitor CBC, renal fxn: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Inzirqo (hydrochlorothiazide)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + penicillamine

    monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentamidine
  • Inzirqo (hydrochlorothiazide)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pentamidine

    monitor renal fxn, BP: combo may incr. risk of nephrotoxicity, severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Inzirqo (hydrochlorothiazide)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • pentobarbital
  • Inzirqo (hydrochlorothiazide)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pentostatin
  • Inzirqo (hydrochlorothiazide)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pentostatin

    monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentoxifylline
  • Inzirqo (hydrochlorothiazide)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pentoxifylline

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perindopril
  • Inzirqo (hydrochlorothiazide)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + perindopril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • perphenazine
  • Inzirqo (hydrochlorothiazide)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + perphenazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of severe hypotension (including orthostasis, syncope), other adverse effects (absorption increased, additive effects)

  • pexidartinib
  • Inzirqo (hydrochlorothiazide)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pexidartinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Inzirqo (hydrochlorothiazide)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phendimetrazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenelzine
  • Inzirqo (hydrochlorothiazide)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Inzirqo (hydrochlorothiazide)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentermine
  • Inzirqo (hydrochlorothiazide)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phentermine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Inzirqo (hydrochlorothiazide)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenylephrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine injection
  • Inzirqo (hydrochlorothiazide)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenylephrine injection

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • phenylephrine nasal
  • Inzirqo (hydrochlorothiazide)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenylephrine nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine rectal
  • Inzirqo (hydrochlorothiazide)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + phenylephrine rectal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • Inzirqo (hydrochlorothiazide)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Inzirqo (hydrochlorothiazide)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + piroxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • plazomicin
  • Inzirqo (hydrochlorothiazide)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + plazomicin

    monitor plazomicin levels, renal fxn, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polyethylene glycol
  • Inzirqo (hydrochlorothiazide)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + polyethylene glycol

    monitor renal fxn, sodium, potassium, consider monitoring ECG if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, renal impairment (additive effects)

  • polyethylene glycol/electrolytes
  • Inzirqo (hydrochlorothiazide)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + polyethylene glycol/ electrolytes

    monitor renal fxn, sodium, potassium, consider monitoring ECG: combo may incr. risk of renal impairment, hyponatremia, seizures, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • polymyxin B
  • Inzirqo (hydrochlorothiazide)
    +
    polymyxin B
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + polymyxin B

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ponatinib
  • Inzirqo (hydrochlorothiazide)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ponatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ponesimod
  • Inzirqo (hydrochlorothiazide)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ponesimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • posaconazole
  • Inzirqo (hydrochlorothiazide)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + posaconazole

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • pralsetinib
  • Inzirqo (hydrochlorothiazide)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pralsetinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pramipexole
  • Inzirqo (hydrochlorothiazide)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Inzirqo (hydrochlorothiazide)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Inzirqo (hydrochlorothiazide)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednisolone
  • Inzirqo (hydrochlorothiazide)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + prednisolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • prednisone
  • Inzirqo (hydrochlorothiazide)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + prednisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • primidone
  • Inzirqo (hydrochlorothiazide)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + primidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • probenecid
  • Inzirqo (hydrochlorothiazide)
    +
    probenecid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + probenecid

    monitor uric acid levels: combo may decr. probenecid efficacy (antagonistic effects)

  • procarbazine
  • Inzirqo (hydrochlorothiazide)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + procarbazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • prochlorperazine
  • Inzirqo (hydrochlorothiazide)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + prochlorperazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • promethazine
  • Inzirqo (hydrochlorothiazide)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + promethazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension, other adverse effects (absorption increased, additive effects)

  • propafenone
  • Inzirqo (hydrochlorothiazide)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + propafenone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propofol
  • Inzirqo (hydrochlorothiazide)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + propofol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • protriptyline
  • Inzirqo (hydrochlorothiazide)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + protriptyline

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • pseudoephedrine
  • Inzirqo (hydrochlorothiazide)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + pseudoephedrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quetiapine
  • Inzirqo (hydrochlorothiazide)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + quetiapine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis, syncope), other adverse effects; may decr. antihypertensive agent efficacy (peds patients) (absorption increased, additive effects; antagonistic effects)

  • quinapril
  • Inzirqo (hydrochlorothiazide)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + quinapril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • quinidine (antiarrhythmic)
  • Inzirqo (hydrochlorothiazide)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + quinidine (antiarrhythmic)

    monitor quinidine levels, ECG: combo may incr. quinidine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (renal excretion possibly decreased at higher urine pH)

  • quinidine (CYP2D6 inhibitor)
  • Inzirqo (hydrochlorothiazide)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + quinidine (CYP2D6 inhibitor)

    monitor ECG: combo may incr. quinidine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (renal excretion possibly decreased at higher urine pH)

  • quinine
  • Inzirqo (hydrochlorothiazide)
    +
    quinine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + quinine

    monitor ECG: combo may incr. quinine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (renal excretion decreased at higher urine pH)

  • rabeprazole
  • Inzirqo (hydrochlorothiazide)
    +
    rabeprazole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rabeprazole

    monitor magnesium, especially w/ rabeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • ramipril
  • Inzirqo (hydrochlorothiazide)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ramipril

    monitor renal function, sodium, BP: combo may increase risk of renal impairment, hyponatremia, hypotension (additive effects)

  • ramucirumab
  • Inzirqo (hydrochlorothiazide)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ramucirumab

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • rasagiline
  • Inzirqo (hydrochlorothiazide)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasburicase
  • Inzirqo (hydrochlorothiazide)
    +
    rasburicase
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rasburicase

    monitor uric acid levels: combo may decr. rasburicase efficacy (antagonistic effects)

  • regorafenib
  • Inzirqo (hydrochlorothiazide)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + regorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • remifentanil
  • Inzirqo (hydrochlorothiazide)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • remimazolam
  • Inzirqo (hydrochlorothiazide)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + remimazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • repaglinide
  • Inzirqo (hydrochlorothiazide)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • Rho(D) immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + Rho(D) immune globulin

    monitor renal fxn; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • rimegepant
  • Inzirqo (hydrochlorothiazide)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rimegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • riociguat
  • Inzirqo (hydrochlorothiazide)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + riociguat

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ripretinib
  • Inzirqo (hydrochlorothiazide)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ripretinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • risperidone
  • Inzirqo (hydrochlorothiazide)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rituximab
  • Inzirqo (hydrochlorothiazide)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rituximab

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rizatriptan
  • Inzirqo (hydrochlorothiazide)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rizatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • romidepsin
  • Inzirqo (hydrochlorothiazide)
    +
    romidepsin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + romidepsin

    monitor sodium, magnesium: combo may incr. risk of hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • ropeginterferon alfa-2b
  • Inzirqo (hydrochlorothiazide)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ropeginterferon alfa-2b

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ropinirole
  • Inzirqo (hydrochlorothiazide)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ropinirole

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • ropivacaine
  • Inzirqo (hydrochlorothiazide)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ropivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • rosiglitazone
  • Inzirqo (hydrochlorothiazide)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Inzirqo (hydrochlorothiazide)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + rotigotine transdermal

    monitor BP: combo may alter blood pressure control (antagonistic effects, additive effects)

  • sacituzumab govitecan
  • Inzirqo (hydrochlorothiazide)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sacituzumab govitecan

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sacubitril
  • Inzirqo (hydrochlorothiazide)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Inzirqo (hydrochlorothiazide)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • salmeterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + salmeterol inhaled

    monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia, ECG changes (antagonistic effects; additive effects)

  • salsalate
  • Inzirqo (hydrochlorothiazide)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + salsalate

    monitor renal fxn, BP w/ high-dose salsalate: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • saxagliptin
  • Inzirqo (hydrochlorothiazide)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Inzirqo (hydrochlorothiazide)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Inzirqo (hydrochlorothiazide)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selinexor
  • Inzirqo (hydrochlorothiazide)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + selinexor

    monitor sodium, potassium: combo may incr. risk of hypokalemia, hyponatremia, including life-threatening (additive effects)

  • selpercatinib
  • Inzirqo (hydrochlorothiazide)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + selpercatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • semaglutide
  • Inzirqo (hydrochlorothiazide)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sertraline
  • Inzirqo (hydrochlorothiazide)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sertraline

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • sevoflurane
  • Inzirqo (hydrochlorothiazide)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sevoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sildenafil
  • Inzirqo (hydrochlorothiazide)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sildenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • silodosin
  • Inzirqo (hydrochlorothiazide)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • siponimod
  • Inzirqo (hydrochlorothiazide)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + siponimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sirolimus
  • Inzirqo (hydrochlorothiazide)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sirolimus albumin-bound
  • Inzirqo (hydrochlorothiazide)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sirolimus albumin-bound

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sitagliptin
  • Inzirqo (hydrochlorothiazide)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sitagliptin

    monitor glucose, renal fxn: combo may incr. risk of nephrotoxicity; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sodium benzoate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium benzoate

    monitor potassium, especially if hyperammonemia use: combo may incr. risk of hypokalemia (additive effects)

  • sodium ferric gluconate complex
  • Inzirqo (hydrochlorothiazide)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sodium phenylacetate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium phenylacetate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium phenylbutyrate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium phenylbutyrate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium picosulfate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium picosulfate

    monitor renal function: combo may incr. risk of renal impairment (additive effects)

  • sodium polystyrene sulfonate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium polystyrene sulfonate

    monitor magnesium, potassium, ECG: combo may incr. risk of hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium thiosulfate
  • Inzirqo (hydrochlorothiazide)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium; otherwise, caution advised: combo may incr. risk of hypokalemia (additive effects)

  • sorafenib
  • Inzirqo (hydrochlorothiazide)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sotagliflozin
  • Inzirqo (hydrochlorothiazide)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Inzirqo (hydrochlorothiazide)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sotalol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sparsentan
  • Inzirqo (hydrochlorothiazide)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sparsentan

    monitor BP, renal fxn: combo may incr. risk of nephrotoxicity, hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Inzirqo (hydrochlorothiazide)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + spironolactone

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • streptomycin
  • Inzirqo (hydrochlorothiazide)
    +
    streptomycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + streptomycin

    monitor renal fxn, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Inzirqo (hydrochlorothiazide)
    +
    streptozocin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + streptozocin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sufentanil
  • Inzirqo (hydrochlorothiazide)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • sulfate bowel prep
  • Inzirqo (hydrochlorothiazide)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sulfate bowel prep

    monitor renal fxn, sodium, potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, renal impairment, hyponatremia, seizures (additive effects)

  • sulindac
  • Inzirqo (hydrochlorothiazide)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sulindac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • sumatriptan
  • Inzirqo (hydrochlorothiazide)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sumatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sunitinib
  • Inzirqo (hydrochlorothiazide)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + sunitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tacrolimus
  • Inzirqo (hydrochlorothiazide)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tacrolimus

    monitor tacrolimus levels, renal fxn, magnesium, BP: combo may incr. tacrolimus levels, risk of nephrotoxicity, hypomagnesemia, cardiac arrhythmias, other adverse effects; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tadalafil
  • Inzirqo (hydrochlorothiazide)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tadalafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tafasitamab
  • Inzirqo (hydrochlorothiazide)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tafasitamab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • tagraxofusp
  • Inzirqo (hydrochlorothiazide)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tagraxofusp

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • tamsulosin
  • Inzirqo (hydrochlorothiazide)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Inzirqo (hydrochlorothiazide)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tapentadol

    monitor BP; consider hydrochlorothiazide dose adjustment: combo may increase risk of severe hypotension, including orthostasis, syncope; may decrease hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • taurine
  • Inzirqo (hydrochlorothiazide)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • telavancin
  • Inzirqo (hydrochlorothiazide)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + telavancin

    monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Inzirqo (hydrochlorothiazide)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + telmisartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • temsirolimus
  • Inzirqo (hydrochlorothiazide)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + temsirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Inzirqo (hydrochlorothiazide)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tenofovir alafenamide

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tenofovir disoproxil
  • Inzirqo (hydrochlorothiazide)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • terazosin
  • Inzirqo (hydrochlorothiazide)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbutaline
  • Inzirqo (hydrochlorothiazide)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + terbutaline

    monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia, ECG changes (antagonistic effects; additive effects)

  • teriflunomide
  • Inzirqo (hydrochlorothiazide)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + teriflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • teriparatide
  • Inzirqo (hydrochlorothiazide)
    +
    teriparatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + teriparatide

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • testosterone
  • Inzirqo (hydrochlorothiazide)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + testosterone

    monitor BP, calcium, especially in cancer pts at incr. risk: combo may incr. risk of hypercalcemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tetrahydrozoline ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tetrahydrozoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thalidomide
  • Inzirqo (hydrochlorothiazide)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Inzirqo (hydrochlorothiazide)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + thioridazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • thiothixene
  • Inzirqo (hydrochlorothiazide)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + thiothixene

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including syncope), other adverse effects (absorption increased, additive effects)

  • thyroid
  • Inzirqo (hydrochlorothiazide)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + thyroid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • timolol ophthalmic
  • Inzirqo (hydrochlorothiazide)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tiopronin
  • Inzirqo (hydrochlorothiazide)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tiopronin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tirzepatide
  • Inzirqo (hydrochlorothiazide)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Inzirqo (hydrochlorothiazide)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tivozanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tizanidine
  • Inzirqo (hydrochlorothiazide)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tobramycin
  • Inzirqo (hydrochlorothiazide)
    +
    tobramycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tobramycin

    monitor tobramycin levels, renal fxn, magnesium, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, hypomagnesemia, cardiac arrhythmias, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    tobramycin inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tobramycin inhaled

    monitor renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tolcapone
  • Inzirqo (hydrochlorothiazide)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolmetin
  • Inzirqo (hydrochlorothiazide)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tolmetin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects)

  • topiramate
  • Inzirqo (hydrochlorothiazide)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + topiramate

    monitor potassium; consider topiramate dose adjustment: combo may incr. topiramate levels, risk of hypokalemia, other adverse effects (mechanism unknown; additive effects)

  • toremifene
  • Inzirqo (hydrochlorothiazide)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + toremifene

    monitor calcium, especially if tumor flare risk: combo may incr. risk of hypercalcemia (possible additive effects)

  • torsemide
  • Inzirqo (hydrochlorothiazide)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + torsemide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • tramadol
  • Inzirqo (hydrochlorothiazide)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tramadol

    monitor sodium, BP: combo may incr. risk of severe hyponatremia, severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • trametinib
  • Inzirqo (hydrochlorothiazide)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + trametinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trandolapril
  • Inzirqo (hydrochlorothiazide)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + trandolapril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • tranylcypromine
  • Inzirqo (hydrochlorothiazide)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Inzirqo (hydrochlorothiazide)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + trazodone

    monitor sodium, BP: combo may incr. risk of hyponatremia, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Inzirqo (hydrochlorothiazide)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamcinolone
  • Inzirqo (hydrochlorothiazide)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + triamcinolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • triamterene
  • Inzirqo (hydrochlorothiazide)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + triamterene

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • trifluoperazine
  • Inzirqo (hydrochlorothiazide)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + trifluoperazine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of severe hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • trimipramine
  • Inzirqo (hydrochlorothiazide)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + trimipramine

    monitor BP: combo may incr. hydrochlorothiazide levels, risk of hypotension (including orthostasis), other adverse effects (absorption increased, additive effects)

  • ubrogepant
  • Inzirqo (hydrochlorothiazide)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ubrogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vaccinia immune globulin
  • Inzirqo (hydrochlorothiazide)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vaccinia immune globulin

    monitor renal fxn; use lowest vaccinia immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • vadadustat
  • Inzirqo (hydrochlorothiazide)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vadadustat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • valacyclovir
  • Inzirqo (hydrochlorothiazide)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + valacyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valganciclovir
  • Inzirqo (hydrochlorothiazide)
    +
    valganciclovir
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + valganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • valsartan
  • Inzirqo (hydrochlorothiazide)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + valsartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • vamorolone
  • Inzirqo (hydrochlorothiazide)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vamorolone

    monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • vancomycin
  • Inzirqo (hydrochlorothiazide)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • vandetanib
  • Inzirqo (hydrochlorothiazide)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vandetanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vardenafil
  • Inzirqo (hydrochlorothiazide)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vardenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • vasopressin
  • Inzirqo (hydrochlorothiazide)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vasopressin

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • venlafaxine
  • Inzirqo (hydrochlorothiazide)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + venlafaxine

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vilanterol inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vilanterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vilazodone
  • Inzirqo (hydrochlorothiazide)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vilazodone

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • viloxazine
  • Inzirqo (hydrochlorothiazide)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + viloxazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • voclosporin
  • Inzirqo (hydrochlorothiazide)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + voclosporin

    monitor renal fxn, BP: combo may incr. risk of nephrotoxicity; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vonoprazan
  • Inzirqo (hydrochlorothiazide)
    +
    vonoprazan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vonoprazan

    monitor magnesium: combo may incr. risk of hypomagnesemia, cardiac arrhythmias (additive effects)

  • vortioxetine
  • Inzirqo (hydrochlorothiazide)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vortioxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • vosoritide
  • Inzirqo (hydrochlorothiazide)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • willow bark
  • Inzirqo (hydrochlorothiazide)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + willow bark

    monitor renal fxn, especially w/ high-dose willow bark: combo may incr. risk of renal impairment; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects; willow bark may contain salicylates)

  • yohimbe
  • Inzirqo (hydrochlorothiazide)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + yohimbe

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • zavegepant
  • Inzirqo (hydrochlorothiazide)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + zavegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ziprasidone
  • Inzirqo (hydrochlorothiazide)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ziv-aflibercept
  • Inzirqo (hydrochlorothiazide)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + ziv-aflibercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zoledronic acid
  • Inzirqo (hydrochlorothiazide)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + zoledronic acid

    monitor renal fxn: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zolmitriptan
  • Inzirqo (hydrochlorothiazide)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + zolmitriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zonisamide
  • Inzirqo (hydrochlorothiazide)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    hydrochlorothiazide + zonisamide

    monitor renal fxn, potassium: combo may incr. risk of renal impairment, hypokalemia (additive effects)

Caution Advised

  • acitretin
  • Inzirqo (hydrochlorothiazide)
    +
    acitretin
    1 interaction

    Caution Advised

    hydrochlorothiazide + acitretin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • aclidinium inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    hydrochlorothiazide + aclidinium inhaled

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • atropine
  • Inzirqo (hydrochlorothiazide)
    +
    atropine
    1 interaction

    Caution Advised

    hydrochlorothiazide + atropine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • belladonna alkaloids
  • Inzirqo (hydrochlorothiazide)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    hydrochlorothiazide + belladonna alkaloids

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • benztropine
  • Inzirqo (hydrochlorothiazide)
    +
    benztropine
    1 interaction

    Caution Advised

    hydrochlorothiazide + benztropine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • brompheniramine
  • Inzirqo (hydrochlorothiazide)
    +
    brompheniramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + brompheniramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • carbinoxamine
  • Inzirqo (hydrochlorothiazide)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + carbinoxamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • chlophedianol
  • Inzirqo (hydrochlorothiazide)
    +
    chlophedianol
    1 interaction

    Caution Advised

    hydrochlorothiazide + chlophedianol

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • chlorcyclizine
  • Inzirqo (hydrochlorothiazide)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    hydrochlorothiazide + chlorcyclizine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • chlorpheniramine
  • Inzirqo (hydrochlorothiazide)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + chlorpheniramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • clemastine
  • Inzirqo (hydrochlorothiazide)
    +
    clemastine
    1 interaction

    Caution Advised

    hydrochlorothiazide + clemastine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • clidinium
  • Inzirqo (hydrochlorothiazide)
    +
    clidinium
    1 interaction

    Caution Advised

    hydrochlorothiazide + clidinium

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • cyclobenzaprine
  • Inzirqo (hydrochlorothiazide)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    hydrochlorothiazide + cyclobenzaprine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • cyproheptadine
  • Inzirqo (hydrochlorothiazide)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    hydrochlorothiazide + cyproheptadine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • darifenacin
  • Inzirqo (hydrochlorothiazide)
    +
    darifenacin
    1 interaction

    Caution Advised

    hydrochlorothiazide + darifenacin

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • dexbrompheniramine
  • Inzirqo (hydrochlorothiazide)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + dexbrompheniramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • dexchlorpheniramine
  • Inzirqo (hydrochlorothiazide)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + dexchlorpheniramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • dicyclomine
  • Inzirqo (hydrochlorothiazide)
    +
    dicyclomine
    1 interaction

    Caution Advised

    hydrochlorothiazide + dicyclomine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • dimenhydrinate
  • Inzirqo (hydrochlorothiazide)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    hydrochlorothiazide + dimenhydrinate

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • diphenhydramine
  • Inzirqo (hydrochlorothiazide)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + diphenhydramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • disopyramide
  • Inzirqo (hydrochlorothiazide)
    +
    disopyramide
    1 interaction

    Caution Advised

    hydrochlorothiazide + disopyramide

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • doxepin topical
  • Inzirqo (hydrochlorothiazide)
    +
    doxepin topical
    1 interaction

    Caution Advised

    hydrochlorothiazide + doxepin topical

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • doxylamine
  • Inzirqo (hydrochlorothiazide)
    +
    doxylamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + doxylamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • fesoterodine
  • Inzirqo (hydrochlorothiazide)
    +
    fesoterodine
    1 interaction

    Caution Advised

    hydrochlorothiazide + fesoterodine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • flavoxate
  • Inzirqo (hydrochlorothiazide)
    +
    flavoxate
    1 interaction

    Caution Advised

    hydrochlorothiazide + flavoxate

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • glycopyrrolate
  • Inzirqo (hydrochlorothiazide)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    hydrochlorothiazide + glycopyrrolate

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • glycopyrronium topical
  • Inzirqo (hydrochlorothiazide)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    hydrochlorothiazide + glycopyrronium topical

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • homatropine
  • Inzirqo (hydrochlorothiazide)
    +
    homatropine
    1 interaction

    Caution Advised

    hydrochlorothiazide + homatropine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • hydroxyzine
  • Inzirqo (hydrochlorothiazide)
    +
    hydroxyzine
    1 interaction

    Caution Advised

    hydrochlorothiazide + hydroxyzine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • hyoscyamine
  • Inzirqo (hydrochlorothiazide)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + hyoscyamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • icosapent ethyl
  • Inzirqo (hydrochlorothiazide)
    +
    icosapent ethyl
    1 interaction

    Caution Advised

    hydrochlorothiazide + icosapent ethyl

    caution advised: combo may antagonize antihyperlipidemic effect of omega-3-acid (antagonistic effects)

  • ipratropium inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    hydrochlorothiazide + ipratropium inhaled

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • meclizine
  • Inzirqo (hydrochlorothiazide)
    +
    meclizine
    1 interaction

    Caution Advised

    hydrochlorothiazide + meclizine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • methoxsalen
  • Inzirqo (hydrochlorothiazide)
    +
    methoxsalen
    1 interaction

    Caution Advised

    hydrochlorothiazide + methoxsalen

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • methscopolamine
  • Inzirqo (hydrochlorothiazide)
    +
    methscopolamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + methscopolamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • orphenadrine
  • Inzirqo (hydrochlorothiazide)
    +
    orphenadrine
    1 interaction

    Caution Advised

    hydrochlorothiazide + orphenadrine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • oxybutynin
  • Inzirqo (hydrochlorothiazide)
    +
    oxybutynin
    1 interaction

    Caution Advised

    hydrochlorothiazide + oxybutynin

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • pheniramine
  • Inzirqo (hydrochlorothiazide)
    +
    pheniramine
    1 interaction

    Caution Advised

    hydrochlorothiazide + pheniramine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • pimozide
  • Inzirqo (hydrochlorothiazide)
    +
    pimozide
    1 interaction

    Caution Advised

    hydrochlorothiazide + pimozide

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • pyrilamine
  • Inzirqo (hydrochlorothiazide)
    +
    pyrilamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + pyrilamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • scopolamine
  • Inzirqo (hydrochlorothiazide)
    +
    scopolamine
    1 interaction

    Caution Advised

    hydrochlorothiazide + scopolamine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • sofpironium topical
  • Inzirqo (hydrochlorothiazide)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    hydrochlorothiazide + sofpironium topical

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • solifenacin
  • Inzirqo (hydrochlorothiazide)
    +
    solifenacin
    1 interaction

    Caution Advised

    hydrochlorothiazide + solifenacin

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • tiotropium inhaled
  • Inzirqo (hydrochlorothiazide)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    hydrochlorothiazide + tiotropium inhaled

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • tolterodine
  • Inzirqo (hydrochlorothiazide)
    +
    tolterodine
    1 interaction

    Caution Advised

    hydrochlorothiazide + tolterodine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • trihexyphenidyl
  • Inzirqo (hydrochlorothiazide)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    hydrochlorothiazide + trihexyphenidyl

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • triprolidine
  • Inzirqo (hydrochlorothiazide)
    +
    triprolidine
    1 interaction

    Caution Advised

    hydrochlorothiazide + triprolidine

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • trospium
  • Inzirqo (hydrochlorothiazide)
    +
    trospium
    1 interaction

    Caution Advised

    hydrochlorothiazide + trospium

    caution advised: combo may incr. hydrochlorothiazide levels, risk of adverse effects (absorption increased)

  • verteporfin
  • Inzirqo (hydrochlorothiazide)
    +
    verteporfin
    1 interaction

    Caution Advised

    hydrochlorothiazide + verteporfin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@6adc595b
  • hypokalemia, severe
  • electrolyte imbalance
  • arrhythmia
  • cholestatic jaundice
  • pancreatitis
  • anaphylaxis
  • necrotizing angiitis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • toxic epidermal necrolysis
  • photosensitivity
  • non-melanoma skin CA
  • renal failure
  • interstitial nephritis
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • hemolytic anemia
  • thrombocytopenia
  • SLE exacerbation
  • glaucoma, acute angle-closure

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@786c0d3a
  • hypokalemia
  • hypochloremia
  • hyponatremia
  • hypomagnesemia
  • hypercalcemia
  • hyperuricemia
  • hyperglycemia
  • hyperlipidemia
  • hypotension, orthostatic
  • dizziness
  • anorexia
  • diarrhea
  • abdominal pain
  • headache
  • weakness
  • muscle cramps
  • photosensitivity
  • rash
  • sexual dysfunction
  • blurred vision

Safety/Monitoring .

Monitoring Parameters
BUN/Cr; electrolytes at baseline, then periodically; dermatologic exams if incr. skin CA risk

Look/Sound-Alike Drug Names
hydroCHLOROthiazide confused with: hydrALAZINE; hydrocortisone; hydroxychloroquine; hydroxyurea; hydrOXYzine; Maxzide

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy if on chronic tx before conception, otherwise weigh risk/benefit; no known risk of teratogenicity based on human data; possible risk of decr. placental perfusion and neonatal adverse effects, including hypoglycemia, thrombocytopenia, and electrolyte abnormalities, based on limited or conflicting human data; risks not observed if chronic use before conception

Lactation

Clinical Summary

avoid use if dose >50 mg/day, otherwise may use while breastfeeding; no known risk of infant harm based on limited human data and drug properties; decr. milk production with high-dose use based on limited human data

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@161dc2c4

Metabolism: for hydrochlorothiazide: none; CYP450: none

Excretion: for hydrochlorothiazide: urine (>61% unchanged); Half-life: 5.6-14.8h

Subclass: Diuretics, Thiazides ; Nephrolithiasis

Mechanism of Action
for hydrochlorothiazide: inhibits distal convoluted tubule sodium and chloride reabsorption

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: ANI Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@5bd15ba5

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information